4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-304786
Chief Executive Officer sold 8,210 shares at an average $40.00 ($328,437)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-07-14 | Sale 10b5-1 | −5,481 | $39.72 | $217,715 | 542,546 | D |
| Ceesay Abraham Chief Executive Officer | 2026-07-14 | Sale 10b5-1 | −2,729 | $40.57 | $110,722 | 539,817 | D |
| Open-market sales · 8,210 sh · avg $40.00 · $328,437 | |||||||
Loading xslF345X06/ownership.xml…